独立药房声称,在药品定价和分销方面,不透明的中间商对独立的药房造成财政压力。 Independent pharmacies claim financial strain from opaque middlemen in drug pricing and distribution.

独立药店声称,由于与大型保健组织有联系的不透明的中间人,药店在财政上受到压力。 Independent pharmacies claim they are being financially strained by opaque middlemen associated with large health organizations. 这些中间人往往参与药品定价和分销,被视为以药店和病人为代价牟利,引起人们对保健系统透明度和公平性的关切。 These intermediaries, often involved in drug pricing and distribution, are seen as profiting at the expense of both pharmacies and patients, raising concerns about transparency and fairness in the healthcare system. 这种情况突出表明了小药店在由较大实体主导的竞争市场中所面临的挑战。 This situation highlights the challenges faced by small pharmacies in a competitive market dominated by larger entities.